Roche sceptical about investing more in 'guided-missile' ADC cancer drugs

FILE PHOTO: A logo of Swiss pharmaceutical company Roche is pictured in front of the company’s building in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer

Friday, June 24, 2022

FILE PHOTO: A logo of Swiss pharmaceutical company Roche is pictured in front of the company’s building in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer

Close